Payden & Rygel Zoetis Inc. Transaction History

Payden & Rygel

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	SELL	$145.54 - $178.83 $15.1 Million - $18.5 Million	-103,590 Closed	0 $0
Q1 2024 Oct 08, 2024	BUY	$165.67 - $199.94 $11.8 Million - $14.2 Million	70,990 New	70,990 $12 Million
Q4 2023 Feb 12, 2024	SELL	$151.44 - $200.09 $257,448 - $340,153	-1,700 Reduced 1.6%	104,390 $20.6 Million
Q3 2023 Oct 07, 2024	SELL	$167.14 - $192.77 $133,712 - $154,216	-800 Reduced 0.77%	103,590 $18 Million
Q2 2023 Aug 10, 2023	BUY	$160.94 - $186.23 $5.5 Million - $6.37 Million	34,200 Added 47.57%	106,090 $18.3 Million
Q1 2023 May 10, 2023	BUY	$145.48 - $175.02 $10.5 Million - $12.6 Million	71,890 New	71,890 $12 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

Stay updated on Payden & Rygel with notifications on news.